- Types of Eczema
- Child Eczema
- Causes & Triggers
- Living with Eczema
- Eczema Products
- Get Involved
Understanding AD’s impact to improve your quality of life People living with atopic dermatitis (AD), the most common and chronic form of eczema, know first-hand the burden AD has on both individuals and families. The impacts reach far beyond the serious effects of the disease symptoms such as itch, pain, and inflammation –they also include […]
We asked, you answered. The verdict? People living with eczema want more information and more options. This past January, many of you responded to a 6-question online survey to evaluate patient satisfaction and the role of doctors in the treatment of the most serious form of eczema, atopic dermatitis (AD). We learned that the vast majority of […]
June 9, 2016 – On Monday, June 6, 2016 the pharmaceutical companies Regeneron and Sanofi, reported positive results for the Phase 3 the clinical trial of the new biologic drug, dupilumab, when used in conjunction with a topical corticosteroid by adults to treat moderate-to-severe atopic dermatitis (AD).
January 11, 2016 – We need to hear from you! We are launching a series of short surveys to make certain we best understand the challenges you face with eczema. Together, we will use this information to fight for your needs, whether you’re an adult with eczema, a child, or parent on the eczema journey. The information you share will shape NEA’s policy priorities for 2016 and beyond, and help us better tell the collective stories about the impact eczema has on your lives.
November 3, 2015 – A research team at Emory University was awarded a NEA Research Grant for their pilot study of the efficacy of meditation for treatment of chronic pruritus (itch). Following is an interview about the study and results, with investigators Mamta Javari, MD, and Suephy Chen, MD.
September 21 – The National Eczema Association (NEA) has awarded Dr. Aaron Drucker, Assistant Professor, Department of Dermatology at Brown University, with the NEA Burden of Disease Research Audit grant, the findings of which will help to raise the profile of eczema as a serious disease, to deliver stronger, more united messages to insurers, medical providers and policy-makers on behalf of the eczema community.
August 3, 2015 – Eczema is the same in any country, in any language. Enjoy this video from our friends in Brazil and share it if you can relate to this family’s story.
NEA formed a Scientific Advisory Committee Task Force to conduct a systematic review of topical corticosteroid withdrawal/topical steroid addiction in patients with atopic dermatitis and other dermatoses, and created a NEA education announcement on Topical Steroid Addiction/Withdrawal.
March 31, 2015 – A ninth-century remedy for eye infections has been found to kill the modern-day superbug MRSA and disrupt naturally antibiotic-resistant biofilms in tests conducted by researchers.
March 10, 2015 – There seem to be three major reasons why patients seek alternative medicine for atopic dermatitis: First, we simply don’t yet have a cure for this disease. Second, we can’t yet clearly explain why this disease occurs. While doctors try hard to describe factors that play a role in atopic dermatitis, such as cytokines and inflammatory cells, we still can’t pinpoint the root of the disease. Third, the outcomes of conventional atopic dermatitis treatments are not always consistent, and sometimes they are perceived as being unsafe.